Brief: Epigenomics issues new shares by way of private placement
24/05/2016 16:56
May 24 (Reuters) - Epigenomics AG ECXn.DE :
* Is raising around 6.8 million euros ($7.58 million) of
gross proceeds in a share capital increase
* Has resolved on increase of company's share capital in
amount of 1,436,000 euros by issuing 1,436,000 new registered
shares of company from authorized capital 2015/I against
contribution in cash
* Issue price has been set at 4.76 euros per share
* Intends to use net proceeds from offering to finance its
current operations and to expand its U.S. commercialization
capacities for its lead product EPI Procolon
Source text for Eikon: ID:nEQ8CK4m9a
Further company coverage: ECXn.DE
($1 = 0.8974 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns